• FCCP Workflows for Mitochondrial and HIF Studies

  2026-08-19

  FCCP enables controlled disruption of oxidative phosphorylation to connect oxygen consumption, ATP production, and hypoxia signaling in cell-based experiments. This guide translates that perturbation into reproducible workflows and shows how it can complement emerging research on mitochondria-derived pre-peroxisomes.

• Dimethyloxalylglycine (DMOG) Protocol Guide

  2026-08-19

  Dimethyloxalylglycine (DMOG), SKU A4506, provides a practical way to induce hypoxia-inducible factor stabilization in cell-based oxygen-sensing, hypoxia signaling, and inflammation studies. It is intended for scientific research only; product-dossier guidance should not be treated as a validated clinical, diagnostic, or universal in vivo dosing protocol.

• Cimetidine for BBB and Cancer Research Workflows

  2026-08-18

  Cimetidine connects a mechanistically distinctive H2-receptor tool with paired MOCK/MDR1 barrier assays and gastrointestinal cancer studies. This workflow emphasizes solvent control, bidirectional transport, recovery correction, and careful interpretation of partial agonism rather than treating the compound as a generic acid-suppression reagent.

• MDockPeP2_VS for Peptide Inhibitor Discovery

  2026-08-18

  The 2024 PNAS Nexus study introduces MDockPeP2_VS, a structure-based workflow that reduces the conformational search burden in large-scale peptide screening by combining molecular docking with structural conservation. Applied to TEM-1 β-lactamase, the method identified TF7 as an experimentally active inhibitor, providing a computational route toward new tools for β-lactam antibiotic resistance research.

• Cimetidine Workflows for H2 and BBB Research

  2026-08-17

  Build reproducible Cimetidine assays for H2 receptor signaling, gastric acid secretion inhibition, and translational cancer research. A validated surrogate BBB workflow adds bidirectional transport, efflux, recovery, and lysosomal-trapping checks without overstating what has been demonstrated for Cimetidine itself.

• JXY, TLR4, and M1 Macrophages in CAC

  2026-08-17

  Liu et al. show that Jiedu Xiaozheng Yin suppresses colitis-associated colorectal cancer in mice while shifting intestinal macrophages toward an M1-like state through TLR4-associated signaling. The study combines an orthotopic cancer model with cellular, molecular, and pharmacological analyses, providing a mechanistic framework for interpreting immune modulation in inflammation-driven colorectal tumorigenesis.

• PKH26 Red Fluorescent Cell Linker Kit Guide

  2026-08-16

  The PKH26 Red Fluorescent Cell Linker Kit provides a membrane-focused red fluorescent label for tracing cells and monitoring signal partitioning during proliferation studies. It is intended for cell membrane lipid-region labeling in vitro and in vivo, not for intracellular structures or non-membrane targets.

• FCCP: A Causal Probe for Immunometabolism

  2026-08-15

  FCCP, or carbonyl cyanide p-trifluoromethoxyphenylhydrazone, is more than a mitochondrial uncoupler: it can serve as a controlled perturbation for separating respiratory effects from macrophage signaling mechanisms. This article connects FCCP assay design with the 25-hydroxycholesterol–AMPK–STAT6 axis while defining what is established and what remains investigational.

• SETD7 Depletion Promotes White Adipose Browning

  2026-08-14

  This study identifies SETD7 as a negative regulator of inguinal white adipose tissue thermogenesis and links its depletion to an Adcy7–Sirt1–CREB1 signaling axis. Genetic and cellular experiments show that reducing SETD7 enhances beige adipocyte activity, increases energy expenditure, and protects obese mice from high-fat diet-associated metabolic deterioration.

• Epacadostat: IDO1 Assays in Whole Blood

  2026-08-14

  Epacadostat (INCB024360) is a selective IDO1 inhibitor for connecting target engagement with immune-function readouts. This article shows how standardized whole-blood stimulation can strengthen IDO1 assay interpretation beyond conventional tumor-cell or enzyme-only systems.

• Carfilzomib Sensitizes 125I Therapy in ESCC

  2026-08-13

  A 2025 Translational Oncology study shows that carfilzomib markedly increases iodine-125 seed radiation efficacy against esophageal squamous cell carcinoma by intensifying endoplasmic reticulum stress. The combination engages apoptosis, paraptosis, and ferroptosis through distinct but convergent stress pathways, providing a mechanistic rationale for radiosensitization.

• Ferroptosis-Related lncRNA Signature in Pancreatic Cancer

  2026-08-13

  This study developed and externally validated a nine-lncRNA ferroptosis-related signature for predicting overall survival and immunotherapy-related differences in pancreatic adenocarcinoma. Its main contribution is a clinically oriented risk model that links ferroptosis-associated transcriptional patterns with prognosis, immune infiltration, and potential treatment-response stratification.

• Fumagillin: From Target Biology to Assay Design

  2026-08-12

  Fumagillin is a methionine aminopeptidase-2 inhibitor with applications in angiogenesis and cancer research. This guide connects its chemical handling and endothelial-cell biology with a carefully interpreted antiparasitic reference study to improve assay design and evidence quality.

• Tacrine Hydrochloride Hydrate for AD Assays

  2026-08-12

  Tacrine hydrochloride hydrate, also known as Tetrahydroaminacrine, supports quantitative cholinesterase inhibition, cholinergic signaling pathway studies, and neuroprotection workflows. This guide connects enzyme-level potency with cell-based Alzheimer’s disease research while emphasizing stock handling, assay controls, and interpretation limits.

• Deferoxamine Mesylate in Ferroptosis Assays

  2026-08-11

  Use Deferoxamine mesylate as an iron-availability control, hypoxia-mimetic probe, and oxidative stress protection tool—not merely as a generic cytoprotectant. This workflow connects upstream iron chelation with the plasma-membrane execution events highlighted in recent ferroptosis research.

16654 records 1/1111 page Next 12345 下5页 Last page